RVNC - Revance Therapeutics Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC)
Q1 2019 Earnings Conference Call
May 08, 2019, 16:30 ET
Company Participants
Jeanie Herbert - Senior Director, IR & Corporate Communications
Daniel Browne - Co-Founder, President, CEO & Director
Tobin Schilke - CFO & Principal Accounting Officer
Dustin Sjuts - Head, Commercial, Aesthetics & Therapeutics
Abhay Joshi - COO
Conference Call Participants
Seamus Fernandez - Guggenheim Securities
Annabel Samimy - Stifel, Nicolaus & Company
Kenneth Cacciatore - Cowen and Company
David Amsellem - Piper Jaffray Companies
Douglas Tsao - H.C. Wainwright & Co.
Myles Minter - William Blair & Company
Alexander